Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | GOSS Gossamer Bio, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $10.99 -2.6% | $15.58 -1.8% |
| StockIQ Score | 34F Weak Risk: High | 37F Weak Risk: Medium |
| Technical | 13F | 16F |
| Fundamental | 42D | 35F |
| Growth | 26F | 50C- |
| Fair Value | 38F | 38F |
| News | 68B- | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Gossamer Bio (GOSS) outperforms Ascentage Pharma (AAPG) in investor and technical strength, scoring 48 and 60 respectively, compared to AAPG’s 37 and 18. AAPG leads in growth potential with a score of 50, while GOSS’s valuation score of 50 matches AAPG’s 38. GOSS has a moderate rating, while AAPG is rated weak.
